Clinical Trial

Intravenous Iron Effects on Performance at High Altitude

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated March 30, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
To compare the effects of IV iron versus placebo (saline) injection on arterial oxygen saturation, submaximal exercise responses, and 2-mile treadmill time-trial performance during acute exposure to hypobaric hypoxia (430 mmHg, simulating \~4800m) assessed 1 and 14 days after treatment. Primary Hypothesis 1: IV iron treatment will improve arterial oxygen saturation at rest and during exercise in acute hypobaric hypoxia and this effect will persist for 2 weeks Primary Hypothesis 2) IV iron treatment will improve 2-mile treadmill time trial performance in acute hypobaric hypoxia and this effect will persist for 2 weeks
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-11-11.
Trial Details
NCT Number NCT06686693
Lead Sponsor United States Army Research Institute of Environmental Medicine
Conditions Hypoxia
Enrollment 24 participants
Start Date 2022-04-15
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-30